SK Biopharmaceuticals Co., Ltd. (KRX:326030)
139,800
+700 (0.50%)
At close: Nov 28, 2025
39.94% (1Y)
| Market Cap | 10.95T |
| Revenue (ttm) | 675.41B |
| Net Income (ttm) | 320.47B |
| Shares Out | 78.31M |
| EPS (ttm) | 4,092.19 |
| PE Ratio | 34.16 |
| Forward PE | 44.12 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 490,024 |
| Average Volume | 430,613 |
| Open | 143,700 |
| Previous Close | 139,100 |
| Day's Range | 137,700 - 144,100 |
| 52-Week Range | 86,900 - 144,100 |
| Beta | 0.83 |
| RSI | 76.03 |
| Earnings Date | Nov 5, 2025 |